logo
DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market

DIAGNOS Welcomes Former White House Economic Adviser Dr. Tomas J. Philipson to its Advisory Board for the US Market

Globe and Mail3 days ago

BROSSARD, Quebec, June 04, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. ('DIAGNOS' or the 'Corporation') (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a pioneer in early detection of critical health issues using advanced technology based on Artificial Intelligence (AI), is thrilled to announce that Dr. Tomas J. Philipson has joined the Corporation's Advisory Board.
Dr. Tomas J. Philipson is considered an expert in US economic policy, particularly health care policy and appears often on major media outlets, including Forbes, The Economist, The Wall Street Journal, The New York Times, CNN, BBC, CBS, ABC, CNBC, Fox News, Fox Business, Newsmax, Yahoo Finance, American Voice, Bloomberg, and CSPAN.
He currently serves as Managing Partner of the VC firm MEDA Ventures, serves on several corporate boards, and has co-founded several companies, including Precision Health Economics LLC, with an exit in 2015 (currently owned by Blackstone).
His government service includes a full-time position as vice chairman and acting chairman of the White House Council of Economic Advisers 2017-20. He previously served as a senior economic adviser to the head of the Food and Drug Administration (FDA) and a senior economic advisor to the head of the Centers for Medicare and Medicaid Services (CMS). Dr. Philipson was appointed to the Key Indicator Commission by the Speaker of the House of Representatives in 2012. He was a scientific advisor to the House of Representatives initiative 21st Century Cures in 2015 and The Biden Cancer Initiative in 2017. He served as a healthcare advisor to Senator John McCain's 2008 presidential campaign.
He received numerous worldwide research awards while he was a chaired professor at the University of Chicago. He is a two-time winner of the Arrow Award of The International Health Economics Association, the highest honor in health economics. Other awards include the Garfield Award for Economic Research, the Prêmio Haralambos Simeonidis from the Brazilian Economic Association, and the Milken Institute's Distinguished Economic Research Award.
He received a B.A. in mathematics from Uppsala University in Sweden, an MA in Mathematics from Claremont Graduate School, and an MA and Ph.D. in Economics from the Wharton School and the University of Pennsylvania.
'We are honored to welcome Dr. Philipson to our Advisor Board,' said André Larente, President and CEO of DIAGNOS. 'His extensive experience at the highest levels of government and business savvy brings a vital perspective to today's policy challenges, from healthcare innovation to long-term economic competitiveness.'
Mr. Larente added, 'DIAGNOS has built an AI platform to analyze retina images, these images are taken by thousands of optometrists worldwide. According to the VisionWatch data, the US saw approximately 111 million routine eye exams and 60 million medical eye exams in 2020. DIAGNOS, along with its partners, can address this growing market.' DIAGNOS recently opened its US office in south Florida to support its prospects and clients.
About DIAGNOS
DIAGNOS is a publicly traded Canadian corporation dedicated to early detection of critical eye-related health problems. By leveraging Artificial Intelligence, DIAGNOS aims to provide more information to healthcare clinicians to enhance diagnostic accuracy, streamline workflows, and improve patient outcomes on a global scale.
Additional information is available at www.diagnos.com and www.sedarplus.com.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Outbreak of forest tent caterpillars should last about 6 weeks
Outbreak of forest tent caterpillars should last about 6 weeks

CTV News

time31 minutes ago

  • CTV News

Outbreak of forest tent caterpillars should last about 6 weeks

Experts say that in northeastern Ontario, the outbreak of forest tent caterpillars this year should last about six weeks. They're creepy, they're crawly and they seem to be everywhere. Forest tent caterpillars are cropping up in large numbers across northeastern Ontario. Experts say we're in an outbreak. 'It's not as severe as it has been in the past,' said Dan Rowlinson, the provincial forest health field coordinator with the Ministry of Natural Resources. Caterpillar1 They're creepy, they're crawly and they seem to be everywhere. Forest tent caterpillars are cropping up in large numbers across northeastern Ontario. (File) 'They're just in the tiny larval stage right now. So, they're just starting to feed on the aspen and the poplar trees. But they'll proceed through the summer and then we'll see more defoliation. I don't think it's going to be as significant as it was last year.' MNR monitoring shows eastern tent caterpillars are a problem, but Rowlinson said they're not as widespread as the forest tent species, also known as armyworms. Those are the ones experiencing the population boom. 'We're looking at about six weeks,' said Alexandra Binns, Science North's animal care technician, who said the area is on the upswing of a 10-year cycle. The last big outbreak was in 2018. 'Mice, rodents, but also birds and migratory birds, it's a quick and easy meal for them. And so as much as we might hate them, they are important to the environment.' — David Dutkiewicz, Invasive Species Centre 'Generally, once the young caterpillars emerge in early springtime, they can only really eat soft or freshly grown leaves,' Binns said. 'Because they can only eat those things, they eat them for about six weeks. That's the fresh start of spring. And then they'll start to cocoon and pupate from there.' Later in the summer, these pests will transform into moths. Caterpillar2 They're creepy, they're crawly and they seem to be everywhere. Forest tent caterpillars are cropping up in large numbers across northeastern Ontario. (Photo from video) Despite their annoyance, experts agree that forest tent caterpillars are important to the ecological landscape. 'They are more nutrients for birds and things like that,' said David Dutkiewicz, an entomology technician with the Invasive Species Centre. 'Mice, rodents, but also birds and migratory birds, it's a quick and easy meal for them. And so as much as we might hate them, they are important to the environment.' Dutkiewicz said picking the forest tent caterpillars off trees and other greenery or wrapping tinfoil around the base of the tree. He said spraying them with soapy water will also work, but doing it too often could harm the tree's protective wax coating. In case children pick one up or they fall from trees onto unsuspecting folks below, it's important to remember the caterpillars aren't harmful to humans, unless there is an allergy to the critters' hairs. Mostly, they're just annoying and gross.

'Lackluster' WWDC Ahead: Apple Stock (NASDAQ:AAPL) Gains as Strategy Questioned
'Lackluster' WWDC Ahead: Apple Stock (NASDAQ:AAPL) Gains as Strategy Questioned

Globe and Mail

timean hour ago

  • Globe and Mail

'Lackluster' WWDC Ahead: Apple Stock (NASDAQ:AAPL) Gains as Strategy Questioned

Consumer electronics giant Apple (AAPL) has been having a bit of a rough time of late, down from the juggernaut it once was, but still very much a part of most people's lives. And with the Worldwide Developers Conference (WWDC) coming up on Monday, difficult questions about Apple's future are being asked. And so far, investors like what they hear, if only somewhat, as Apple shares notched up fractionally in Friday afternoon's trading. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Apple Intelligence has not exactly reached the levels that Apple was hoping for, and this after a year in play. Many of Apple's competitors in this field have made substantial advances, but Apple remains a technological laggard. And with Eddy Cue, Apple's head of services, noting that users '…may not need an iPhone 10 years from now,' that represented a combination of events that definitely did not look good for Apple. But with the WWDC about to fire up in earnest, the focus is shifting to Apple's AI plans, and what it is looking to do now. With that very real possibility that Apple's hardware dominance could be on thin ice, hearing Apple's next moves in the market will be vital to ensuring that shareholders remain interested. However, Samik Chatterjee —who has a five-star rating on TipRanks—with JPMorgan noted that, right now, investors are expecting a 'lackluster' event. What Should Appear The news is difficult enough for Apple right now, but what will it likely roll out at the big show? Reports suggest that a new naming convention for iOS will emerge. While iOS was previously on iOS 18, it will not go to iOS 19. Rather, it will instead go to iOS 26, reports note, as the new convention requires the iOS be the year instead of the version number. Apple is also reportedly planning a major shakeup in the way its software looks. Some figure that it will change to better reflect the Vision Pro's operating system, though there are certain doubts as to how that will work, exactly. Apple may also uncase another app for social gaming, as the Game Center could use a bit of a replacement. But one thing that will likely not show up at WWDC, reports note, is any kind of new hardware. And if this is the case, that 'lackluster' projection of Chatterjee's might be dead-on. Is Apple a Buy, Hold or Sell? Turning to Wall Street, analysts have a Moderate Buy consensus rating on AAPL stock based on 16 Buys, nine Holds and four Sells assigned in the past three months, as indicated by the graphic below. After a 1.9% rally in its share price over the past year, the average AAPL price target of $228.65 per share implies 12.83% upside potential. See more AAPL analyst ratings Disclosure Disclaimer & Disclosure Report an Issue

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store